Kramer v. Scientific Control Corp.

452 F. Supp. 812, 26 Fed. R. Serv. 2d 700, 1978 U.S. Dist. LEXIS 17383
CourtDistrict Court, E.D. Pennsylvania
DecidedJune 6, 1978
DocketCiv. A. 71-1954
StatusPublished
Cited by6 cases

This text of 452 F. Supp. 812 (Kramer v. Scientific Control Corp.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kramer v. Scientific Control Corp., 452 F. Supp. 812, 26 Fed. R. Serv. 2d 700, 1978 U.S. Dist. LEXIS 17383 (E.D. Pa. 1978).

Opinion

MEMORANDUM

BECHTLE, District Judge.

Presently before the Court are the motions of defendants Arthur Andersen and Company (“Andersen”), Ernest E. Specks (“Specks”), William C. Weatherford (“Weatherford”) and Van Calvin Ellis (“Ellis”) 1 for summary judgment pursuant to Fed.R.Civ.P. 56. 2 For the reasons stated below, these motions will be granted in part and denied in part.

Plaintiffs Mitchell A. Kramer and David C. Harrison filed their original complaint 3 *814 on August 9, 1971, naming as defendants Scientific Control Corporation (“Scientific”),, Andersen (Scientific’s accountant), Specks (a director of Scientific) and various other officers, directors and underwriters of Scientific. The original complaint alleged a conspiracy among the defendants to defraud purchasers of common stock issued by Scientific on or about October 31,1968, and asserted claims based upon §§ 11, 12(2), 15 and 17(a) of the Securities Act of 1933 (“1933 Act”), as amended, 15 U.S.C. §§ 77a et seq.; §§ 9(a)(4), 10(b) and 18 of the Securities Exchange Act of 1934 (“Exchange Act”), as amended, 15 U.S.C. §§ 78a et seq.; rules and regulations of the Securities and Exchange Commission (“SEC”) promulgated under both Acts; and common law. The jurisdiction of this Court was invoked pursuant to § 22(a) of the 1933 Act, 15 U.S.C. § 77v(a); § 27 of the Exchange Act, 15 U.S.C. § 78aa; and pendent jurisdiction. By authority of this Court’s Order of November 10, 1971, plaintiffs filed an amended complaint on November 12, 1971, which, inter alia, added Weatherford and Ellis as defendants. A second amended complaint, which retained Andersen, Specks, Weatherford and Ellis as defendants, was filed February 7, 1973.

Andersen’s Motion

In support of its motion for summary judgment, in which Specks, Ellis and Weatherford join, Andersen argues, first, that plaintiffs’ claims pursuant to §§ 12(2) 4 and 15 5 of the 1933 Act, 15 U.S.C. §§ 777 (2), 77o, must be dismissed because the plaintiffs have failed to establish that: (a) there was a buyer-seller relationship between plaintiffs and the moving defendants; or (b) that the moving defendants had control over plaintiffs’ seller or any other defendants. We agree. We have previously ruled that a prerequisite to the imposition of liability based upon § 12(2) is strict privity between the buyer and the immediate seller. Kramer v. Scientific Control Corp., 365 F.Supp. 780, 791 (E.D.Pa.1973), citing Dorfman v. First Boston Corp., 336 F.Supp. 1089, 1091-1096 (E.D.Pa.1972). While we are aware that other courts have upheld an exception to the privity requirement where the complaint alleges a conspiracy among the defendants, see In Re Caesar’s Palace Securities Litigation, 360 F.Supp. 366, 378-383 (S.D.N.Y.1973); cf. B & B Investment Club v. Kleinert’s Inc., 391 F.Supp. 720, 725-726 (E.D.Pa.1975), we adhere to the reasoning and holding of Dorfman, supra in which Chief Judge Joseph S. Lord, III, specifically rejected the conspiracy exception. Dorfman v. First Boston Corp., supra, 336 F.Supp. at 1092. The pleadings, depositions and exhibits in this case clearly establish that the plaintiffs purchased their Scientific stock from Merrill, Lynch, Pierce, Fenner & Smith, a brokerage firm which was not an underwriter of the Scientific stock nor named as a de *815 fendant in this suit. See e. g., Kramer deposition, pp. 30, 41-42. In addition, neither the original complaint nor the amendments to it allege that privity existed between plaintiffs and the moving defendants. We find, therefore, that Andersen, Specks, Weatherford and Ellis have satisfied their burden of establishing that there is no genuine issue with respect to the material fact of the lack of privity between plaintiffs and the moving defendants and that they are entitled to summary judgment in their favor on plaintiffs’ claims under § 12(2).

We find, further, that the moving defendants have also met their burden of establishing that there is no genuine issue as to whether Andersen, Specks, Weather-ford or Ellis had control over plaintiffs’ seller or any other defendant in this case which would subject them to liability based upon § 15. Liability based upon § 15 6 requires that the direct seller be liable under § 12(2) and that a control relationship have existed between the direct seller and the defendants. Dorfman v. First Boston Corp., supra, 336 F.Supp. at 1093. Because the complaint fails to name the direct seller as a defendant, to allege liability based upon § 12(2) against the direct seller or to allege that Andersen, Specks, Weatherford or Ellis had a control relationship with the direct seller or any of the defendants, the moving defendants are entitled to summary judgment in their favor on plaintiffs’ claims pursuant to § 15.

Next, Andersen argues that plaintiffs’ claims pursuant to § 17(a) 7 of the 1933 Act, 15 U.S.C. § 77q(a) must be dismissed because, as a matter of law, § 17(a) does not create an implied private right of action, particularly where the plaintiff has also alleged a claim pursuant to § 11 of the 1933 Act, 15 U.S.C. § 77k. We have previously held that §§ 17(a)(1) and (3) permit private actions for fraud in the offer or sale of securities and that § 17(a)(2) permits private actions subject to the limitations of § 12. Kramer v. Scientific Control Corp., supra, 365 F.Supp. at 791, citing Dorfman v. First Boston Corp., supra, 336 F.Supp. at 1093-1096. Since our ruling in Kramer, supra, both the Supreme Court, see Blue Chip Stamps v. Manor Drug Stores, 421 U.S. 723, 734 n. 6, 95 S.Ct. 1917, 44 L.Ed.2d 539 (1975), and the Third Circuit, see Schultz v. Cally, 528 F.2d 470, 475 n. 11 (3d Cir.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
452 F. Supp. 812, 26 Fed. R. Serv. 2d 700, 1978 U.S. Dist. LEXIS 17383, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kramer-v-scientific-control-corp-paed-1978.